Bookmark

Add to MyYahoo RSS

Eli Lilly News

News on Eli Lilly (Ticker: LLY) continually updated from thousands of sources around the net.

Yesterday | Pharmaceutical Online

Lilly Invests Millions On New Anti-Counterfeiting Serialization Program

Over the next two years, Eli Lilly will be strengthening its efforts against counterfeiting with a $110 million investment in a new serialization program for its drug packages.

Comment?

Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry

Mon Apr 14, 2014

Drugs.com

Boehringer Ingelheim and Eli Lilly Announce NDA Filing for Empagliflozin and Linagliptin Combination

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the U.S. Food and Drug Administration accepted the filing of the New Drug Application for the investigational combination tablet of empagliflozin and linagliptin for the treatment of adults with type 2 diabetes .

Comment?

Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry, Food and Drug Administration, Diabetes, Health, Insulin (generic), Humulin, Novolin

Wall Street Journal

Eli Lilly vs. Canada: The Patent War Moves to Washington

Its efforts underscore growing frustration the pharmaceutical industry has toward some foreign governments over patent rights, although much of the vitriol has often been directed toward India.

Comment?

Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry

AmericanBankingNews.com

Eli Lilly and Upgraded to "Hold" by Jefferies

The firm currently has a $54.00 target price on the stock, up from their previous target price of $45.00.

Comment?

Related Topix: Alnara Pharmaceuticals, Biotech, Food, Medicine, Avid Radiopharmaceuticals, Agriculture, International Multifoods Corporation, Eli Lilly, Imclone Systems, Healthcare Industry

AmericanBankingNews.com

Eli Lilly and PT Raised to $54.00

The firm currently has a "hold" rating on the stock. A number of other analysts have also recently weighed in on LLY.

Comment?

Related Topix: Alnara Pharmaceuticals, Biotech, Food, Medicine, Avid Radiopharmaceuticals, Agriculture, International Multifoods Corporation, Eli Lilly, Imclone Systems, Healthcare Industry

Fri Apr 11, 2014

Freshnews

Lilly Confirms Date and Conference Call for First-Quarter 2014 Financial Results Announcement

Eli Lilly and Company will announce its financial results for the first quarter of 2014 on Thursday, April 24, 2014.

Comment?

Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry

Thu Apr 10, 2014

Big News Network.com

Takeda and Eli Lilly to appeal $9bn punitive damages ordered by court

Our eNewspaper network was founded in 2002 to provide stand-alone digital news sites tailored for the most searched-for locations for news.

Comment?

Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry, Actos, Pioglitazone (generic), Diabetes, Health, bladder cancer

Palladium-Item

Indiana lawmakers weigh in on drug patent dispute

Indiana lawmakers want the Obama administration to increase pressure on Canada over the country's handling of pharmaceutical patents.

Comment?

Related Topix: Indiana, Biotech, Medicine, Eli Lilly, Healthcare Industry

Business Journal

Biotech company's progress brings cash, new CEO

A Kansas biotech company said it has new money, and a new CEO, as one of its cancer treatment drugs progressed to Phase I clinical trials.

Comment?

Related Topix: Cancer, Medicine, Health

Wed Apr 09, 2014

The Japan Times

Pharmaceutical giant Takeda to fight $6 billion damages ruling by...

Takeda Pharmaceutical Co. said it would contest $6 billion in punitive damages imposed by a jury in the United States in a case that accused Japan's largest drugmaker of concealing cancer risks associated with its Actos diabetes drug.

Comment?

Related Topix: Medicine, Diabetes, Health, Biotech, Eli Lilly, Healthcare Industry, 9, Exxon Mobil, Energy, Oil & Gas, US News, US Supreme Court

Tue Apr 08, 2014

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

Johnson comes to Bizwom... )--A U.S. jury's combined $9 billion judgment against Japan's Takeda Pharmaceutical partner company Eli Lilly will not affect LLY's ratings, according to Fitch Ratings... )--FUND db x-trackers Stoxx Europe 600 Technology UCITS ETF DEALING DATE 7-Apr-14 NAV PER SHARE EUR39.7009 NUMBER OF SHARES IN ISSUE 310,533 CODE ... (more)

Comment?

Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry, Manufacturing, AB Electrolux, Saab AB, Appliances, Aerospace-Defense

WTHR-TV Indianapolis

US jury hits Eli Lilly, Takeda with $9B penalty

Testifying in his murder trial on Tuesday, Oscar Pistorius said he and girlfriend Reeva Steenkamp sometimes had troubles in their relationship but that they sorted them out, were in love and were planning Testifying in his murder trial on Tuesday, Oscar Pistorius said he and girlfriend Reeva Steenkamp sometimes had troubles in their relationship ... (more)

Comment?

Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry, Indianapolis, IN, Drugs

Mon Apr 07, 2014

The Washington Post

Takeda, Lilly Jury Awards $9 Billion Over Hiding Actos Risks

Takeda Pharmaceutical Co. and Eli Lilly & Co. were ordered to pay a combined $9 billion after a federal court jury found they hid the cancer risks of their Actos diabetes medicine in the first U.S. trial of its kind.

Comment?

Related Topix: Actos, Pioglitazone (generic), Medicine, Biotech, Eli Lilly, Healthcare Industry, Diabetes, Health, Lafayette, LA

Customer Interaction Solutions

Deciphera Pharmaceuticals Announces Initiation of Phase 1 Cancer Trial for LY3009120

Deciphera Pharmaceuticals, a clinical stage biotechnology company focused on improved kinase inhibitor treatments for cancer, today announced the initiation of a Phase 1 clinical trial of its pan-RAF inhibitor LY3009120 , under development in collaboration with Eli Lilly.

Comment?

Related Topix: Biotech, Eli Lilly, Medicine, Healthcare Industry, Oncology

Sun Apr 06, 2014

The Washington Post

Pfizer, Lilly Drugs slow advanced breast cancer in studies

Experimental breast cancer drugs from Pfizer and Eli Lilly slowed or halted the growth of advanced tumors in studies, potentially adding a new treatment option for patients and top-selling therapies for the companies.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Eli Lilly

Sat Apr 05, 2014

The Indianapolis Star

Eli Lilly intensifies efforts to stop fake pharmaceuticals

The drug fakery came to the attention of Eli Lilly and Co. in 2007, when a British packager noticed upside-down batch numbers on blister packs of Zyprexa, a popular medicine to treat schizophrenia.

Comment?

Related Topix: Drugs, Biotech, Medicine, Eli Lilly, Healthcare Industry, Zyprexa, Zydis, Olanzapine (generic), Indianapolis, IN

Thu Apr 03, 2014

AmericanBankingNews.com

Cowen & Company Upgrades Eli Lilly and to Outperform

The firm currently has a $68.00 price objective on the stock, up from their previous price objective of $61.00.

Comment?

Related Topix: Alnara Pharmaceuticals, Biotech, Food, Medicine, Avid Radiopharmaceuticals, Agriculture, International Multifoods Corporation, Eli Lilly, Imclone Systems, Healthcare Industry

AmericanBankingNews.com

Eli Lilly and Upgraded by Cowen and Company to Outperform

Eli Lilly and opened at 59.15 on Thursday. Eli Lilly and has a one year low of $47.53 and a one year high of $60.12.

Comment?

Related Topix: Alnara Pharmaceuticals, Biotech, Food, Medicine, Avid Radiopharmaceuticals, Agriculture, International Multifoods Corporation, Eli Lilly, Imclone Systems, Healthcare Industry

Mon Mar 31, 2014

Sys-Con Media

U.S. District Court Upholds Validity of Lilly's Alimta Patent Through 2022

In the case of Eli Lilly and Company v. Teva Parenteral Medicines Inc., et al ., the court ruled the vitamin dosage regimen patent is valid and enforceable.

Comment?

Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry

BayStreet.ca

Wall Street Fundamentals Releases New In-Depth Stock Reports on CAT,...

U.S. markets closed higher Friday as gains in the energy and consumer sectors more than offset the losses in the health-care and technology sectors.

Comment?

Related Topix: Financial Markets, Manufacturing, Construction, Insurance, Caterpillar, EOG Resources, Energy, Oil & Gas, Biotech, Medicine, Eli Lilly, Healthcare Industry, Merck

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••
•••